These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12763687)

  • 21. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity.
    Mahajan SD; Aalinkeel R; Parikh NU; Jacob A; Cwiklinski K; Sandhu P; Le K; Loftus AW; Schwartz SA; Quigg RJ; Alexander JJ
    Immunol Invest; 2017 Nov; 46(8):816-832. PubMed ID: 29058550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.
    Saifuddin M; Parker CJ; Peeples ME; Gorny MK; Zolla-Pazner S; Ghassemi M; Rooney IA; Atkinson JP; Spear GT
    J Exp Med; 1995 Aug; 182(2):501-9. PubMed ID: 7543140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.
    Yang K; Lan J; Shepherd N; Hu N; Xing Y; Byrd D; Amet T; Jewell C; Gupta S; Kounga C; Gao J; Yu Q
    J Virol; 2015 Sep; 89(18):9393-406. PubMed ID: 26136568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement-Opsonized HIV-1 Alters Cross Talk Between Dendritic Cells and Natural Killer (NK) Cells to Inhibit NK Killing and to Upregulate PD-1, CXCR3, and CCR4 on T Cells.
    Ellegård R; Khalid M; Svanberg C; Holgersson H; Thorén Y; Wittgren MK; Hinkula J; Nyström S; Shankar EM; Larsson M
    Front Immunol; 2018; 9():899. PubMed ID: 29760706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane-bound hemagglutinin mediates antibody and complement-dependent lysis of influenza virus-treated human platelets in autologous serum.
    Kazatchkine MD; Lambré CR; Kieffer N; Maillet F; Nurden AT
    J Clin Invest; 1984 Sep; 74(3):976-84. PubMed ID: 6470149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV and complement: hijacking an immune defense.
    Datta PK; Rappaport J
    Biomed Pharmacother; 2006 Nov; 60(9):561-8. PubMed ID: 16978830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV and complement: role of the complement system in HIV infection.
    Marschang P; Ebenbichler CF; Dierich MP
    Int Arch Allergy Immunol; 1994; 103(2):113-7. PubMed ID: 8292898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement-HIV interactions during all steps of viral pathogenesis.
    Stoiber H; Banki Z; Wilflingseder D; Dierich MP
    Vaccine; 2008 Jun; 26(24):3046-54. PubMed ID: 18191309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism.
    Sullivan BL; Takefman DM; Spear GT
    Virology; 1998 Sep; 248(2):173-81. PubMed ID: 9721226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1.
    Ellegård R; Crisci E; Andersson J; Shankar EM; Nyström S; Hinkula J; Larsson M
    J Immunol; 2015 Aug; 195(4):1698-704. PubMed ID: 26157174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis.
    Spear GT; Sullivan BL; Takefman DM; Landay AL; Lint TF
    Immunology; 1991 Aug; 73(4):377-82. PubMed ID: 1916889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivity.
    Yefenof E; Asjö B; Klein E
    Int Immunol; 1991 Apr; 3(4):395-401. PubMed ID: 1878340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.
    Moir S; Malaspina A; Li Y; Chun TW; Lowe T; Adelsberger J; Baseler M; Ehler LA; Liu S; Davey RT; Mican JA; Fauci AS
    J Exp Med; 2000 Sep; 192(5):637-46. PubMed ID: 10974030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tracing complement-retroviral interactions from mucosal surfaces to the lymphatic tissue.
    Banki Z; Soederholm A; Mullauer B; Dierich MP; Stoiber H
    Front Biosci; 2007 Jan; 12():2096-106. PubMed ID: 17127447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus and the complement system.
    Gras G; Legendre C; Richard Y; Dormont D
    Exp Clin Immunogenet; 1997; 14(1):11-5. PubMed ID: 9187917
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18).
    Bajtay Z; Speth C; Erdei A; Dierich MP
    J Immunol; 2004 Oct; 173(8):4775-8. PubMed ID: 15470016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons.
    Speth C; Schabetsberger T; Mohsenipour I; Stöckl G; Würzner R; Stoiber H; Lass-Flörl C; Dierich MP
    J Virol; 2002 Apr; 76(7):3179-88. PubMed ID: 11884542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement dependent trapping of infectious HIV in human lymphoid tissues.
    Bánki Z; Kacani L; Rusert P; Pruenster M; Wilflingseder D; Falkensammer B; Stellbrink HJ; van Lunzen J; Trkola A; Dierich MP; Stoiber H
    AIDS; 2005 Mar; 19(5):481-6. PubMed ID: 15764853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells.
    Bouhlal H; Chomont N; Haeffner-Cavaillon N; Kazatchkine MD; Belec L; Hocini H
    J Immunol; 2002 Sep; 169(6):3301-6. PubMed ID: 12218150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.